JMH USD
J36
ST Engineering
S63
UOB
U11
CapitaLandInvest
9CI
OCBC Bank
O39
SG Stock MarketDetailed Quotes
42C IX Biopharma
- 0.021
- 0.0000.00%
10min DelayTrading Mar 21 15:05 CST
18.59MMarket Cap-1.75P/E (TTM)
0.000High0.000Low0Volume0.000Open0.021Pre Close0.00Turnover0.05552wk High0.00%Turnover Ratio885.04MShares0.00152wk Low-0.012EPS TTM9.62MFloat Cap0.640Historical HighLossP/E (Static)457.91MShs Float0.001Historical Low-0.014EPS LYR0.00%Amplitude--Dividend TTM5.25P/B100Lot Size--Div YieldTTM
IX Biopharma Key Stats
EPS
According to the latest financial report of IX Biopharma, the latest earnings per share (TTM) for the company is -0.36. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: SGD
Quarterly
Loading...
FCF
Interested in knowing about IX Biopharma's free cash flow? The latest report shows it as -2.75M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: SGD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of IX Biopharma shows that the company's current ratio is 0.78, indicating healthy liquidity.
Currency: SGD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of IX Biopharma, the quick ratio is 0.58, indicating that the company can meet its short-term debt obligations.
Currency: SGD
Quarterly
Loading...
ROE
Want to learn more about the financial health of IX Biopharma? The latest ROE figure is -14.78%, indicating that the company has stable profitability.
Currency: SGD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of IX Biopharma, the total asset return on investment (ROA) is -10.68%.
Currency: SGD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check IX Biopharma's latest financial report to see how their gross margin is doing - currently at -91.95%.
Currency: SGD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of IX Biopharma, the net profit margin is -1.39K%, which is a good sign for its profitability.
Currency: SGD
Quarterly
Loading...
Market Insights
SG High Dividend SG High Dividend
Singapore's high dividend stocks offer a compelling investment opportunity for those seeking to generate regular income while participating in the potential growth of some of the region's most stable companies. By understanding the benefits and challenges associated with these stocks and conducting thorough research before investing, individuals can effectively incorporate high dividend stocks into their investment strategy. Always consider consulting with financial advisors to tailor investments to your personal financial goals and risk tolerance. With the right approach, high dividend stocks can be a valuable addition to a well-rounded investment portfolio. Singapore's high dividend stocks offer a compelling investment opportunity for those seeking to generate regular income while participating in the potential growth of some of the region's most stable companies. By understanding the benefits and challenges associated with these stocks and conducting thorough research before investing, individuals can effectively incorporate high dividend stocks into their investment strategy. Always consider consulting with financial advisors to tailor investments to your personal financial goals and risk tolerance. With the right approach, high dividend stocks can be a valuable addition to a well-rounded investment portfolio.